Page 2 - Terity Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements Specialty Finance Portfolio Growth, Underlying Credit Performance Highlight Strong 2020 Closed Four Transactions During 2020, Deploying $35 Million Two Milestone Payments Received from Cara Therapeutics Related to the Development of Oral KORSUVA™ Fourth Quarter and Full-Year 2020 Financial Results Expected in March 2021 News provided by Share this article Share this article DALLAS, Feb. 16, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small ...

Share this article Share this article LOS ANGELES, Dec. 18, 2020 /PRNewswire/ -- DxTerity Diagnostics is pleased to announce a strategic collaboration with Amazon to distribute its SARS-CoV-2 diagnostic tests to U.S. small businesses and customers at home. The self-administered, non-invasive saliva kits are FDA authorized for use by both individuals with and without symptoms of COVID-19. The kits are now available in individual and 10-pack kits on Amazon.  DxTerity's SARS-CoV-2 PCR-based test is the first at-home saliva test to receive Emergency Use Authorization (EUA) by the FDA for symp...